Collagen Turnover Markers in Relation to Future Cardiovascular and Noncardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis.
暂无分享,去创建一个
[1] D. Jacobs,et al. Comparison of the Predictive Value of GlycA and Other Biomarkers of Inflammation for Total Death, Incident Cardiovascular Events, Noncardiovascular and Noncancer Inflammatory-Related Events, and Total Cancer Events. , 2016, Clinical chemistry.
[2] R. Wei,et al. Serum levels of PSA, ALP, ICTP, and BSP in prostate cancer patients and the significance of ROC curve in the diagnosis of prostate cancer bone metastases. , 2016, Genetics and molecular research : GMR.
[3] J. Phillip,et al. The Mechanobiology of Aging. , 2015, Annual review of biomedical engineering.
[4] D. Jacobs,et al. High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis , 2015, Journal of the American Heart Association.
[5] D. Wasserman,et al. The extracellular matrix and insulin resistance , 2015, Trends in Endocrinology & Metabolism.
[6] M. Connelly,et al. GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation. , 2015, Clinical chemistry.
[7] D. Siscovick,et al. Urine Collagen Fragments and CKD Progression-The Cardiovascular Health Study. , 2015, Journal of the American Society of Nephrology : JASN.
[8] E. Rimm,et al. Fibrosis-related biomarkers and risk of total and cause-specific mortality: the cardiovascular health study. , 2014, American journal of epidemiology.
[9] Stephane Heymans,et al. Myocardial Extracellular Matrix: An Ever-Changing and Diverse Entity , 2014, Circulation research.
[10] F. Villarreal,et al. Dynamic Changes in Myocardial Matrix and Relevance to Disease: Translational Perspectives , 2014, Circulation research.
[11] S. Zakynthinos,et al. Procollagen type III aminoterminal propeptide as biomarker of host response in severe sepsis. , 2013, Journal of critical care.
[12] Harold I Feldman,et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.
[13] T. Wynn,et al. Mechanisms of fibrosis: therapeutic translation for fibrotic disease , 2012, Nature Medicine.
[14] J. Gottdiener,et al. The Relationship Between Serum Markers of Collagen Turnover and Cardiovascular Outcome in the Elderly: The Cardiovascular Health Study , 2011, Circulation. Heart failure.
[15] H. Langberg,et al. Interleukin-6: a growth factor stimulating collagen synthesis in human tendon. , 2011, Journal of applied physiology.
[16] Valerie M. Weaver,et al. The extracellular matrix at a glance , 2010, Journal of Cell Science.
[17] E. Benjamin,et al. Relations of Biomarkers of Extracellular Matrix Remodeling to Incident Cardiovascular Events and Mortality , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[18] Douglas W DeSimone,et al. The extracellular matrix in development and morphogenesis: a dynamic view. , 2010, Developmental biology.
[19] Arantxa González,et al. Circulating Biomarkers of Collagen Metabolism in Cardiac Diseases , 2010, Circulation.
[20] F. Zannad,et al. Extracellular matrix fibrotic markers in heart failure , 2010, Heart Failure Reviews.
[21] B. Pitt,et al. Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure: Insights From the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Study , 2009, Circulation.
[22] J. Laurila,et al. Markers of collagen synthesis and degradation are increased in serum in severe sepsis: a longitudinal study of 44 patients , 2009, Critical care.
[23] J. Varga,et al. Scleroderma: from cell and molecular mechanisms to disease models. , 2005, Trends in immunology.
[24] G. Gabbiani,et al. The myofibroblast in wound healing and fibrocontractive diseases , 2003, The Journal of pathology.
[25] A. Teppo,et al. Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients , 2003, Transplantation.
[26] R. Kronmal,et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.
[27] C. Belluco,et al. Colorectal cancer metastatic phenotype stimulates production by fibroblasts of N-terminal peptide of type III collagen: clinical implications for prognosis. , 2001, Clinica chimica acta; international journal of clinical chemistry.
[28] F. Stenbäck,et al. Collagen Matrix in Development and Progression of Experimentally Induced Respiratory Neoplasms in the Hamster , 2001, Toxicologic pathology.
[29] C. Belluco,et al. Metastatic colorectal cancer stimulates collagen synthesis by fibroblasts. , 2001, Anticancer research.
[30] N. Afdhal,et al. Hepatic fibrosis: Are any of the serum markers useful? , 2001, Current gastroenterology reports.
[31] J. Risteli,et al. Type III and type I procollagen markers in fibrosing alveolitis. , 1999, American journal of respiratory and critical care medicine.
[32] F. Stentz,et al. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. , 1998, American journal of respiratory and critical care medicine.
[33] C. Brown,et al. Urinary and serum type III collagen: markers of renal fibrosis. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[34] W. Graninger,et al. Increased serum concentrations of the carboxy‐terminal cross‐linked telopeptide of collagen type I in patients with Gram‐negative septicaemia , 1996, European journal of clinical investigation.
[35] D J Prockop,et al. Collagens: molecular biology, diseases, and potentials for therapy. , 1995, Annual review of biochemistry.
[36] J. Risteli,et al. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. , 1993, Clinical chemistry.
[37] C. Waydhas,et al. Increased serum concentrations of procollagen type III peptide in severely injured patients: An indicator of fibrosing activity? , 1993, Critical care medicine.
[38] J. Risteli,et al. Aminoterminal propeptide of type III procollagen in serum during wound healing in human beings. , 1990, Surgery.